Evidence map›Paper›PMID 29121869›Full record

ArticleBMC cancer2017

Ablation of epidermal RXRα in cooperation with activated CDK4 and oncogenic NRAS generates spontaneous and acute neonatal UVB induced malignant metastatic melanomas.

Sharmeen Chagani, Rong Wang, Evan L Carpenter, Christiane V Löhr, Gitali Ganguli-Indra, Arup K Indra

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Crosstalk in Skin: Loss of Desmoglein 1 in Keratinocytes Inhibits BRAFThe Journal of investigative dermatology · 2025
    Article
  2. Article
  3. Review
  4. UVB mutagenesis differs inLife science alliance · 2021
    Article
  5. Classification and Grading of Melanocytic Lesions in a Mouse Model ofThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2021
    Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sharmeen ChaganiMolecular and Cellular Biology Program, OSU, Corvallis, 97331, OR, USA.
Rong WangDepartment of Pharmaceutical Sciences, College of Pharmacy, OSU, Corvallis, 97331, OR, USA.
Evan L CarpenterDepartment of Pharmaceutical Sciences, College of Pharmacy, OSU, Corvallis, 97331, OR, USA.
Christiane V LöhrCollege of Veterinary Medicine, Oregon State University, Corvallis, Oregon, 97331, USA.
Gitali Ganguli-IndraMolecular and Cellular Biology Program, OSU, Corvallis, 97331, OR, USA.
Arup K IndraMolecular and Cellular Biology Program, OSU, Corvallis, 97331, OR, USA. Arup.Indra@oregonstate.edu.
Oregon State University · USCorvallis Environmental Center · USOregon Health & Science University · US

Funding

National Institutes of Health ES016629-01A1
6 · The paper itself

Abstract

backgroundUnderstanding the underlying molecular mechanisms involved in the formation of cutaneous malignant melanoma is critical for improved diagnosis and treatment. Keratinocytic nuclear receptor Retinoid X Receptor α (RXRα) has a protective role against melanomagenesis and is involved in the regulation of keratinocyte and melanocyte homeostasis subsequent acute ultraviolet (UV) irradiation.

methodsWe generated a trigenic mouse model system (RXRα

resultsHere we report that the trigenic mice develops spontaneous melanoma and exposure to a single neonatal UVB treatment reduces the tumor latency in those mice compared to control mice with functional RXRα. Melanomas from the trigenic RXRα

conclusionsOur study demonstrates the protective role of keratinocytic RxRα in (1) suppressing spontaneous and acute UVB-induced melanoma, and (2) preventing progression of the melanoma to malignancy in the presence of driver mutations like activated CDK4

Indexed as

Ablation TechniquesAcute DiseaseAnimalsAnimals, NewbornCarcinogenesisCutaneous Malignant MelanomaCyclin-Dependent Kinase 4GTP PhosphohydrolasesMaleMelanomaMembrane ProteinsMiceMice, KnockoutMice, TransgenicRetinoid X Receptor alphaSkin NeoplasmsCdk4 protein, mouseCyclin-Dependent Kinase 4GTP PhosphohydrolasesMembrane ProteinsNRAS protein, humanRetinoid X Receptor alphaAcute UVBCDK4R24C/R24CKeratinocytesMalignant melanomaMelanocytesMicroenvironmentNRASQ61KRetinoid-X-receptor α (RXRα)Spontaneous melanomaTrigenic

Identifiers

PMID29121869
PMCPMC5679438
OpenAlexW2768025708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.